Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Clinical trial NCT05477576 · RECRUITING

Trial details

NCT number: NCT05477576
Sponsor: RayzeBio, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

GEP-NET Gastroenteropancreatic Neuroendocrine Tumor Gastroenteropancreatic Neuroendocrine Tumor Disease Neuroendocrine Tumors Carcinoid Carcinoid Tumor Pancreatic NET

Start date: 2022-03-24
Primary completion: 2026-12-01
Enrollment: 338

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.